» Articles » PMID: 35573706

Crosstalk Between CD4 T Cells and Synovial Fibroblasts from Human Arthritic Joints Promotes Hyaluronan-dependent Leukocyte Adhesion and Inflammatory Cytokine Expression in Vitro

Abstract

The content and organization of hyaluronan (HA) in the extracellular matrix (ECM) have been identified as strong indicators of inflammation in joint disease, although the source and role of HA as an effector of inflammation is not clear. In this study, we established co-cultures of activated human CD4 T cells with fibroblast-like synoviocytes (FLS) from osteoarthritis (OA) and rheumatoid arthritis (RA) subjects and examined the role of HA in promoting inflammatory events. Co-cultures of RA FLS with activated CD4 T cells generated an HA-enriched ECM that promoted enhanced monocyte adhesion compared to co-cultures of OA FLS with activated CD4 T cells. In addition, both OA FLS and RA FLS co-cultures with activated CD4 T cells elicited significant increases in the expression of IL1β, TNF, and IL6, with the increase in IL6 expression most prominent in RA co-cultures. Blocking HA synthesis and accumulation with 4-methylumbelliferone reduced expression of IL6, IL1β, and TNF in both OA FLS and RA FLS co-cultures. The increase in HA synthesis in the co-cultures was mimicked by IL6 trans-signaling of FLS in the absence of CD4 T cells. Inhibition of HA synthesis blocked the increase in IL6 by RA FLS mediated by IL6 trans-signaling, suggesting that the HA synthetic pathway may be a key mediator in IL6 expression by FLS. Overall, our study indicates that HA-enriched ECM generated by co-cultures of activated CD4 T cells with FLS from human joints creates a pathogenic microenvironment by promoting adhesion of leukocytes and expression of inflammatory cytokines including IL6.

Citing Articles

Patient-Specific Variability in Interleukin-6 and Myeloperoxidase Responses in Osteoarthritis: Insights from Synthetic Data and Clustering Analysis.

Coleman L, Byrne J, Edwards S, OHara R J Pers Med. 2025; 15(1).

PMID: 39852209 PMC: 11766770. DOI: 10.3390/jpm15010017.


Immunotherapeutic potential of collagen V oral administration in mBSA/CFA-induced arthritis.

da Silveira L, Velosa A, Catanozi S, Pereira M, Dos Santos Filho A, Marques F PLoS One. 2024; 19(10):e0311263.

PMID: 39378196 PMC: 11460680. DOI: 10.1371/journal.pone.0311263.


Minoxidil weakens newly synthesized collagen in fibrotic synoviocytes from osteoarthritis patients.

Sarkovich S, Issa P, Longanecker A, Martin D, Redondo K, McTernan P J Exp Orthop. 2023; 10(1):84.

PMID: 37605092 PMC: 10441905. DOI: 10.1186/s40634-023-00650-8.


Role and mechanism of fibroblast-activated protein-α expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis.

Wang Z, Wang J, Lan T, Zhang L, Yan Z, Zhang N Front Immunol. 2023; 14:1135384.

PMID: 37006278 PMC: 10064071. DOI: 10.3389/fimmu.2023.1135384.

References
1.
Fichtner-Feigl S, Strober W, Kawakami K, Puri R, Kitani A . IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med. 2005; 12(1):99-106. DOI: 10.1038/nm1332. View

2.
Hundhausen C, Roth A, Whalen E, Chen J, Schneider A, Long S . Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression. Sci Transl Med. 2016; 8(356):356ra119. PMC: 5125295. DOI: 10.1126/scitranslmed.aad9943. View

3.
Page T, Charles P, Piccinini A, Nicolaidou V, Taylor P, Midwood K . Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res Ther. 2012; 14(6):R260. PMC: 3674624. DOI: 10.1186/ar4105. View

4.
Powell J, Horton M . Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res. 2005; 31(3):207-18. DOI: 10.1385/IR:31:3:207. View

5.
Nagy N, Kuipers H, Frymoyer A, Ishak H, Bollyky J, Wight T . 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol. 2015; 6:123. PMC: 4369655. DOI: 10.3389/fimmu.2015.00123. View